← Back to Clinical Trials
Recruiting NCT07176793

NCT07176793 Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07176793
Status Recruiting
Phase
Sponsor University of California, Davis
Condition Gestational Diabetes Mellitus (GDM)
Study Type OBSERVATIONAL
Enrollment 10 participants
Start Date 2026-03-23
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Implementation mapping to develop a multilevel health system strategy for prevention of type 2 diabetes through targeted breastfeeding support for patients with gestational diabetes

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10 participants in total. It began in 2026-03-23 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators will use implementation methods to develop better breastfeeding support for patients with gestational diabetes as a way to prevent type 2 diabetes.

Eligibility Criteria

Inclusion Criteria: * ≥18 years old and able to communicate in English * Fits into one of the following: 1. patients with GDM who are recently pregnant and/or postpartum; 2. health care providers (nurses, physicians, lactation consultants, etc.) who would implement the strategy 3. executive leadership Exclusion Criteria: * Subjects not meeting the inclusion criteria will be considered ineligible for participation

Contact & Investigator

Central Contact

Adrienne Hoyt-Austin, DO, MAS, IBCLC

✉ aehoyt@health.ucdavis.edu

📞 916-734-4580

Principal Investigator

Adrienne Hoyt-Austin, DO, MAS, IBCLC

PRINCIPAL INVESTIGATOR

UC Davis Health

Frequently Asked Questions

Who can join the NCT07176793 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gestational Diabetes Mellitus (GDM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07176793 currently recruiting?

Yes, NCT07176793 is actively recruiting participants. Contact the research team at aehoyt@health.ucdavis.edu for enrollment information.

Where is the NCT07176793 trial being conducted?

This trial is being conducted at Sacramento, United States.

Who is sponsoring the NCT07176793 clinical trial?

NCT07176793 is sponsored by University of California, Davis. The principal investigator is Adrienne Hoyt-Austin, DO, MAS, IBCLC at UC Davis Health. The trial plans to enroll 10 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology